In order to define new prognostic subgroups in patients with glioblastoma a miRNA screen (> 1000 miRNAs) from paraffin tissues followed by a bio-mathematical analysis was performed. 35 glioblastoma patients treated between 7/2005 - 8/2008 at a single institution with surgery and postoperative radio(chemo)therapy were included in this retrospective analysis. For microarray analysis the febit biochip "Geniom® Biochip MPEA homo-sapiens" was used. Total RNA was isolated from FFPE tissue sections and 1100 different miRNAs were analyzed. It was possible to define a distinct miRNA expression pattern allowing for a separation of distinct prognostic subgroups. The defined miRNA pattern was significantly associated with early death v...
and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients ...
Background: Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor with poor cl...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient medi...
Background: In order to define new prognostic subgroups in patients with glioblastoma a miRNA screen...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient medi...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient medi...
<div><p>The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (...
The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (World He...
The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (World He...
Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment ...
Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment ...
<div><p>Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, th...
Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, there is a...
Although patients with Glioblastoma multiforme (GBM) have grave prognosis, significant variability i...
Although patients with Glioblastoma multiforme (GBM) have grave prognosis, significant variability i...
and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients ...
Background: Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor with poor cl...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient medi...
Background: In order to define new prognostic subgroups in patients with glioblastoma a miRNA screen...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient medi...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient medi...
<div><p>The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (...
The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (World He...
The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (World He...
Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment ...
Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment ...
<div><p>Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, th...
Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, there is a...
Although patients with Glioblastoma multiforme (GBM) have grave prognosis, significant variability i...
Although patients with Glioblastoma multiforme (GBM) have grave prognosis, significant variability i...
and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients ...
Background: Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor with poor cl...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient medi...